The estimated Net Worth of Todd Inman is at least 5.61 千$ dollars as of 1 March 2023. Mr. Inman owns over 771 units of OptimizeRx Corp stock worth over 5,613$ and over the last 3 years he sold OPRX stock worth over 0$. In addition, he makes 0$ as Chief Technology Officer at OptimizeRx Corp.
Todd has made over 1 trades of the OptimizeRx Corp stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 771 units of OPRX stock worth 5,613$ on 1 March 2023.
The largest trade he's ever made was exercising 771 units of OptimizeRx Corp stock on 1 March 2023 worth over 5,613$. On average, Todd trades about 257 units every 0 days since 2022. As of 1 March 2023 he still owns at least 771 units of OptimizeRx Corp stock.
You can see the complete history of Mr. Inman stock trades at the bottom of the page.
Todd Inman serves as Chief Technology Officer of the Company. Inman brings to the position more than 30 years of experience delivering outcomes across the healthcare technology industry. Since joining OptimizeRx in January 2019 as VP of Technology, he has led the company's technology innovation teams in the U.S., Europe and Israel. Inman has overseen OptimizeRx's establishment of a state-of-the-art AWS cloud backbone, data and analytics infrastructure, and the recently announced OptimizeRx Innovation Lab. He will continue leading the implementation and development of the company's newly integrated communications platform. Prior to OptimizeRx, Inman has held leadership roles within prominent health technology and information services companies. While leading data solutions at a large publicly traded health IT company, Inman directed the design and implementation of the company's big data strategy. This resulted in an AWS cloud-based data asset of over 30 billion digital health records for 230 million patients. With this highly secured and compliant health information asset, he led artificial intelligence, machine learning, and business intelligence efforts that resulted in the creation of numerous solutions benefiting providers, payers, and patients.
Todd's mailing address filed with the SEC is C/O OPTIMIZERX CORPORATION, 400 WATER STREET, SUITE 200, ROCHESTER, MI, 48307.
Over the last 2001 years, insiders at OptimizeRx Corp have traded over 20,012,815$ worth of OptimizeRx Corp stock and bought 258,753 units worth 1,128,145$ . The most active insiders traders include Investment Company, Inc. Awm、Bradley Louis Radoff、David Harrell. On average, OptimizeRx Corp executives and independent directors trade stock every 32 days with the average trade being worth of 183,485$. The most recent stock trade was executed by Patrick D Spangler on 5 June 2024, trading 10,061 units of OPRX stock currently worth 73,244$.
optimizerx partners with pharmaceutical companies to offer electronic versions of their patient savings and support materials within the eprescribing workflow of leading electronic health record platforms. using the samplemd technology, providers can more efficiently distribute savings and support materials to their patients. the ecoupon technology, available in the eprescribing workflow of over 300,000+ providers, has expanded the distribution of savings and support materials to millions of patients throughout the us and aims to increase adherence rates and affordability of prescribed medications. about optimizerx corp. optimizerx corp. provides unique consumer and physician platforms to help patients better afford and comply with their medications, while offering pharmaceutical companies effective ways to expand awareness, affordability and adherence to their brands. for more information on samplemd, please call us at (877) 568-3840 or visit www.samplemd.com.
OptimizeRx Corp executives and other stock owners filed with the SEC include: